This study, written by Cardinal Fernández et al., aims to analyse the clinical usefulness of lactate clearance (CL6) in assessing the prognosis of patients admitted to the Intensive Care Unit (ICU). In conclusion, lactate clearance in the first 6 hours of treatment might be helpful in distinguishing the prognosis in the ICU.
The main contribution of this study, published by Cardinal Fernández et al. under the title “Prognostic Value Of Lactate Clearance In The First 6 Hours Of Intensive Medicine Course”, is to show that the CL6 is able to contribute to the discrimination of the prognosis of patients admitted to the ICU with blood lactate level > 2 mEq/l.
The authors reached the conclusion that in critical surgical patients with lactate level > 2 mEq/l, lactate clearance in the first 6 hours of treatment might be helpful in discerning the prognosis in the ICU. The CL6 is a low cost biomarker which is widely available in intensive care centers; values ≤ 0,4 after initial resuscitation could justify a change in the established treatment.
More information at Laktate.